Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone,ethinylestradiol -

Israel - English - Ministry of Health

easy care ltd, israel - drospirenone; ethinylestradiol - film coated tablets - ethinylestradiol 0.02 mg; drospirenone 3 mg - drospirenone and estrogen - - oral contraception.- treatment of moderate acne vulgaris in women who seek oral contraception.- treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of ethinylestradiol and drospirenone combination for pmdd was not assessed beyond 3 cycles. ethinylestradiol and drospirenone combination has not been evaluated for treatment of pms ( premenstrual syndrome ).

Kenya - English - Pharmacy and Poisons Board

sun pharmaceutical industries limited sun house 201 b/1, goregaon, mumbai, india - drospirenone usp and ethinyl estradiol usp - coated tablet - drospirenone usp - 3.0 mg; ethinyl estradiol usp… - hormonal contraceptives: fixed combinations of

Canada - English - Health Canada

bayer inc - drospirenone; ethinyl estradiol; levomefolate calcium; levomefolate calcium - tablet - 3.00mg; 0.02mg; 0.451mg; 0.451mg - drospirenone 3.00mg; ethinyl estradiol 0.02mg; levomefolate calcium 0.451mg; levomefolate calcium 0.451mg - contraceptives

Canada - English - Health Canada

apotex inc - drospirenone; ethinyl estradiol - tablet - 3.00mg; 0.02mg - drospirenone 3.00mg; ethinyl estradiol 0.02mg - contraceptives

Canada - English - Health Canada

lupin limited - drospirenone; ethinyl estradiol - tablet - 3.0mg; 0.02mg - drospirenone 3.0mg; ethinyl estradiol 0.02mg - contraceptives

Canada - English - Health Canada

bayer inc - drospirenone; levomefolate calcium; levomefolate calcium; ethinyl estradiol - tablet - 3.0mg; 0.451mg; 0.451mg; 0.03mg - drospirenone 3.0mg; levomefolate calcium 0.451mg; levomefolate calcium 0.451mg; ethinyl estradiol 0.03mg - contraceptives

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - estetrol monohydrate, quantity: 15 mg (equivalent: estetrol, qty 14.2 mg); drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; hypromellose; hyprolose; purified talc; hydrogenated cottonseed oil; lactose monohydrate; maize starch - nextstellis is indicated for use by women of reproductive potential to prevent pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 0.02 mg - tablet - excipient ingredients: polacrilin potassium; lactose monohydrate; magnesium stearate - zaida 3/20 is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg/ethinyloestradiol 20 ?g tablets for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg/ethinyloestradiol 20 ?g tablets has not been evaluated for treatment of pms (premenstrual syndrome) (see clinical trials).

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - drospirenone ; ethinylestradiol - film coated tablet - 0.03 / 3 milligram - drospirenone and ethinylestradiol